 |  | 

ABSTRACT: Timing of radiotherapy in breast cancer conserving treatment
The optimal timing and sequencing of adjuvant radiotherapy and
chemotherapy after breast-conserving surgery for early invasive
breast cancer is controversial.
Several studies demonstrated
that postoperative radiation therapy significantly reduces the
incidence of breast recurrences.
For patients who do not need
systemic treatment, the interval between surgery and the start
of radiotherapy should not exceed eight weeks. For node-positive
and high-risk patients receiving breast-conserving treatment,
adjuvant chemotherapy should be administered prior to radiotherapy,
but the delay of radiation should not exceed 20-24 weeks.
Side
effects and complications of radiotherapy can be expected to
increase when chemotherapy is administered concurrently.
In particular,
antracycline-based chemotherapy regimens increase the damage
to heart muscle and coronary arteries: to avoid the risk of ischemic
cardiovascular disease, radiotherapy must be performed after
the end of systemic treatment.
[05/30/2002; Cancer Treatment Reviews]ABSTRACT: Timing of radiotherapy in breast cancer conserving treatment
The optimal timing and sequencing of adjuvant radiotherapy and
chemotherapy after breast-conserving surgery for early invasive
breast cancer is controversial.
Several studies demonstrated
that postoperative radiation therapy significantly reduces the
incidence of breast recurrences.
For patients who do not need
systemic treatment, the interval between surgery and the start
of radiotherapy should not exceed eight weeks. For node-positive
and high-risk patients receiving breast-conserving treatment,
adjuvant chemotherapy should be administered prior to radiotherapy,
but the delay of radiation should not exceed 20-24 weeks.
Side
effects and complications of radiotherapy can be expected to
increase when chemotherapy is administered concurrently.
In particular,
antracycline-based chemotherapy regimens increase the damage
to heart muscle and coronary arteries: to avoid the risk of ischemic
cardiovascular disease, radiotherapy must be performed after
the end of systemic treatment.
[05/30/2002; Cancer Treatment Reviews]
|
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|